Dr. Modi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4100 John R St
Detroit, MI 48201Phone+1 313-576-8780Fax+1 313-576-8661
Education & Training
- Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019
- Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2012 - 2015
- Wayne State University School of MedicineClass of 2015
Certifications & Licensure
- MI State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- HematologyHematology
- Medical OncologyMedical Oncology
Awards, Honors, & Recognition
- ASH Abstract Achievement Award American Society of Hematology, 2017
Publications & Presentations
PubMed
- 8 citationsImpact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid
Leukemia. 2023-05-01 - 3 citationsPost-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor, Martin Maiers, Javier Bolaños-Meade
Journal of Clinical Oncology. 2024-10-01 - 21 citationsIncidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation.Dipenkumar Modi, Hyejeong Jang, Seongho Kim, Abhinav Deol, Lois Ayash
American Journal of Hematology. 2016-09-01
Journal Articles
- Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.Modi D, Ye JC, Surapaneni M, Singh V, Chen W, Jang H, Deol A, Ayash L, Alavi A, Ratanatharathorn V, Uberti JP, American Journal of Hematology, 7/10/2019
Abstracts/Posters
- Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Re...Dipenkumar Modi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hemato...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
- Grant to Barbara Ann Karmanos Cancer Institute Funds Study to Identify DLBCL Patients Likely to Relapse Post Autologous Stem Cell TransplantationApril 6th, 2021
- Karmanos Cancer Center Gets $320,000 Federal Grant for Lymphoma ResearchApril 5th, 2021
- Karmanos Cancer Institute Receives a $325,372 Grant from U CAN-CER VIVE FoundationMarch 29th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Hindi, Gujarati
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: